Morphine Oral - Elan Corporation: Avinza™

Author：  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.3, 2002-01, pp. : 208-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Avinza® – 24-h sustained-release oral morphine therapy

By Caldwell Jacques R  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 469-472

Informa Healthcare

Access to resources Recommend Favorite

In vitro observations indicate that alcohol compromises the controlled-release characteristics of Kadian [morphine] and Avinza [morphine]

By  

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Safety updates to US labelling for Avinza

By  

Reactions Weekly, Vol. 1, Iss. 1077, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Opioid maintenance therapy with slow release oral morphine: Experience from India

By Rao Ravindra   Dhawan Anju   Sapra Neerja  

Journal of Substance Use, Vol. 10, Iss. 5, 2005-10 ,pp. : 259-261

Radcliffe Press

Access to resources Recommend Favorite

Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers

By Villesen Hanne   Kristensen Kim   Hansen Steen   Jensen Niels-Henrik   Skram Ulrik   Christrup Lona  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 8, 2007-08 ,pp. : 761-767

Springer Publishing Company

Access to resources Recommend Favorite